Skip to main content
    H

    HeartSciences Inc. (HSCS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.06
    -0.02 (-0.96%)

    Market Cap: $10.56M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    HeartSciences Inc. (HSCS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    HeartSciences (HSCS) has a market cap of $10.56M and an enterprise value of $14.39M. Its share count is up 181.46% from a year earlier.

    Total Valuation

    Enterprise value is 36.27% above the market cap, as debt exceeds cash.

    Market Cap$10.56M
    Enterprise Value$14.39M
    Latest price (Nov 17, 2026)$2.06

    Key Dates

    The next earnings report is expected on Dec 21, 2026, covering the quarter ending Oct 31, 2026.

    Next Earnings DateDec 21, 2026 (expected)
    Last Earnings DateSep 14, 2026
    Fiscal Year EndApril

    Share Statistics

    The share count grew 228.69% a year over 3 years.

    Shares Outstanding3.67M
    Shares Change (YoY)+181.46%
    Share Count Growth (3Y CAGR)+228.69%

    Price Statistics

    The stock is down 32.90% over 52 weeks and trades 40.29% below its 50-day average.

    Beta (1Y)0.72
    52-Week Change-32.90%
    1-Month Change-32.90%
    3-Month Change-19.06%
    6-Month Change+9.57%
    Total Return (1Y)-32.90%
    Total Return (3Y CAGR)-50.08%
    Return vs SPY (1Y)-43.57%
    Max Drawdown (1Y)-60.38%
    Max Drawdown (3Y)-93.74%
    Sharpe Ratio (1Y)-0.37
    Correlation with SPY (1Y)0.09
    50-Day Average$3.45
    200-Day Average$2.67
    52-Week Range$1.63 to $5.25
    RSI (14 Days)31.5
    Average Volume (20 Days)90.60K

    Price chart

    Financial Position

    Current assets cover 0.14x current liabilities.

    Current Ratio0.14x
    Quick Ratio0.07x
    Interest Coverage-11.75x

    Returns and Efficiency

    Return on invested capital is -408.80% over the last 12 months.

    Return on Assets (ROA)-274.52%
    Return on Invested Capital (ROIC)-408.80%
    Inventory Turnover0.00x

    Scores

    HSCS has an Altman Z-Score of -42.24, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-42.24
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Balance Sheet

    Cash and Equivalents$29.91K
    Total Debt$3.86M
    Net Debt$3.83M
    Net Debt Per Share$1.04
    Working Capital-$4.82M
    Shareholder Equity-$2.03M
    Tangible Book Value-$4.69M
    Total Assets$3.74M
    Total Liabilities$5.77M

    Balance sheet as of Jul 31, 2026.

    Full balance sheet

    Cash Flow

    After $28.80M of capital spending, operating cash flow left -$35.59M of free cash flow.

    Operating Cash Flow-$6.79M
    Capital Expenditures$28.80M
    Free Cash Flow-$35.59M
    FCF Per Share-$7.35
    Depreciation and Amortization$65.18M

    Trailing 12 months through Jul 31, 2026.

    Full cash flow statement

    Growth

    Revenue fell 5.70% a year over 3 years.

    Revenue Growth (3Y CAGR)-5.70%
    Revenue Growth (5Y CAGR)-29.95%

    Revenue and profit by year

    Stock Splits

    The last split was a 1-for-100 reverse split on May 17, 2024.

    Last Split DateMay 17, 2024
    Split TypeReverse split
    Split Ratio1:100

    Analyst Forecast

    Consensus estimates put revenue growth at 2600.62% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+2600.62%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About HSCS

    What is HSCS's market cap?

    HeartSciences has a market cap of $10.56M. Its enterprise value, which adds debt and subtracts cash, is $14.39M.

    How many shares of HSCS are outstanding?

    HeartSciences has 3.67M shares outstanding. The count is up 181.46% from a year earlier.

    Does HSCS pay a dividend?

    No. HeartSciences does not pay a dividend.

    How much debt does HSCS have?

    HeartSciences has $3.86M of total debt and $29.91K of cash and equivalents, a net debt position of $3.83M.